Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-obesity device
MedTech
ReShape unveils $6M offering, stock falls 50%
The financing gives ReShape, formerly known as EnteroMedics, money to commercialize its weight loss devices, but the move caused investors to buck.
Nick Paul Taylor
Apr 2, 2018 10:50am
Gelesis raises $30M to gear up for weight loss launch
Mar 2, 2018 9:00am
GI Dynamics loses CE mark over quality nonconformance
Nov 13, 2017 8:45am
Enteromedics rebrands as ReShape LifeSciences—News of Note
Oct 25, 2017 11:42am
Gelesis’ pivotal obesity trial hits one endpoint, misses another
Sep 25, 2017 9:05am
Apollo bags CE mark for longer-term obesity balloon
Sep 1, 2017 9:58am
